Clinical Risk Grouping Solutions Market By Product, By Deployment, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market

CHAPTER 4: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Data Visualization Tools
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Data Visualization Tools Clinical Risk Grouping Solutions Market by Type
4.2.4.1 Software Market size and forecast, by region
4.2.4.2 services Market size and forecast, by region
4.3 Data Analytics
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country

CHAPTER 5: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT
5.1 Overview
5.1.1 Market size and forecast
5.2 Private Cloud
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Public Cloud
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Hybrid Cloud
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country

CHAPTER 6: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Healthcare service providers
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Helthcare payers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country

CHAPTER 7: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.2.1 North America Data Visualization Tools Clinical Risk Grouping Solutions Market by Type
7.2.3 North America Market size and forecast, by Deployment
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U. S.
7.2.5.1.1 Market size and forecast, by Product
7.2.5.1.2 Market size and forecast, by Deployment
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product
7.2.5.2.2 Market size and forecast, by Deployment
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product
7.2.5.3.2 Market size and forecast, by Deployment
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.2.1 Europe Data Visualization Tools Clinical Risk Grouping Solutions Market by Type
7.3.3 Europe Market size and forecast, by Deployment
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product
7.3.5.1.2 Market size and forecast, by Deployment
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product
7.3.5.2.2 Market size and forecast, by Deployment
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Product
7.3.5.3.2 Market size and forecast, by Deployment
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product
7.3.5.4.2 Market size and forecast, by Deployment
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product
7.3.5.5.2 Market size and forecast, by Deployment
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product
7.3.5.6.2 Market size and forecast, by Deployment
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.2.1 Asia-Pacific Data Visualization Tools Clinical Risk Grouping Solutions Market by Type
7.4.3 Asia-Pacific Market size and forecast, by Deployment
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Product
7.4.5.1.2 Market size and forecast, by Deployment
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Product
7.4.5.2.2 Market size and forecast, by Deployment
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Product
7.4.5.3.2 Market size and forecast, by Deployment
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Product
7.4.5.4.2 Market size and forecast, by Deployment
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 Rest of Asia-Pacific
7.4.5.5.1 Market size and forecast, by Product
7.4.5.5.2 Market size and forecast, by Deployment
7.4.5.5.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.2.1 LAMEA Data Visualization Tools Clinical Risk Grouping Solutions Market by Type
7.5.3 LAMEA Market size and forecast, by Deployment
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product
7.5.5.1.2 Market size and forecast, by Deployment
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Product
7.5.5.2.2 Market size and forecast, by Deployment
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Product
7.5.5.3.2 Market size and forecast, by Deployment
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Product
7.5.5.4.2 Market size and forecast, by Deployment
7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Players
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES
9.1 Conduent Inc
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 3M Corporation
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Optum, Inc
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Cerner Corporation
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Nuance Communications
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Health Catalyst, Inc
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 HBI Solutions
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Johns Hopkins University
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Lightbeam Health Solutions
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Dynamic Healthcare Systems
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

Executive Summary

According to this report, titled, 'Clinical Risk Grouping Solutions Market,' the clinical risk grouping solutions market was valued at $0.4 billion in 2021, and is estimated to reach $1.6 billion by 2031, growing at a CAGR of 14.6% from 2022 to 2031.

The clinical risk grouping solutions are a kind of software created to improve a facility's overall clinical operations. It is accomplished by grouping patients based on the severity of their demands and the resources that the hospital has available. This system places a strong emphasis on assessing patient data, facility data, and resource availability.

The increasing focus on healthcare risk management, the increase in population, and the adoption of cloud-based deployment drive the growth of the Clinical Risk Grouping Solutions Industry. Furthermore, an increase in the prevalence of chronic diseases such as cancer and diabetes boosts the patient pool. For instance, according to International Diabetes Federation (IDF), in 2021, approximately 537 million adults (20-79 years) are living with diabetes. The clinical risk grouping solutions are useful for clinical prediction and decision-making for healthcare workers.

Furthermore, Clinical Risk Grouping Solutions Market Trends that drive the growth of the clinical risk grouping solutions market include R&D for the development of advanced and user-friendly clinical risk grouping solutions, an increase in product approvals, and new products launched in the market. In addition, the integration of various tools backed by artificial intelligence (AI) and big data in the current healthcare setting for monitoring clinical information and utilizing it for getting better outputs contributes to the growth of the Clinical Risk Grouping Solutions Industry.

The clinical risk grouping solutions market is segmented into product, deployment model, end user, and region.

On the basis of product, the market is divided into data visualization tools and data analytics. The data visualization tools segment dominated the Clinical Risk Grouping Solutions Market Share in 2021, and this trend is expected to continue during the Clinical Risk Grouping Solutions Market Forecast period, owing to advancements in data visualization tools and the rise in the prevalence of chronic diseases.

Based on the deployment model, the market is categorized into private cloud, public cloud, and hybrid cloud. The private cloud segment dominated the Clinical Risk Grouping Solutions Market Size in 2021, and this trend is expected to continue during the forecast period, owing to the increasing incidence of preterm childbirth and advancements in clinical risk grouping solutions tools.

Depending on end user, the market is classified into a healthcare service provider, and healthcare payers. The healthcare service provider companies segment dominated the Clinical Risk Grouping Solutions Market Size in 2021, and this trend is expected to continue during the Clinical Risk Grouping Solutions Market Analysis period, owing to increase in healthcare expenditure and rise in number of healthcare service providers.

North America accounted for a majority of the global clinical risk grouping solutions market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to increase in number of key players and growing healthcare expenditure. Asia-Pacific is anticipated to witness lucrative growth, owing to rise in prevalence of public cloud, high birth rate and presence of key players in the region.

Key findings of the study

On the basis of product, the data visualization tools segment was the highest contributor to the market in 2021.

Based on the deployment model, the private cloud segment was the highest contributor to the market in 2021.

Depending on the end user, the healthcare service providers segment was the highest contributor to the market in 2021.

Region wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Companies Mentioned

• Conduent Inc.
• 3M Corporation
• Optum, Inc.
• Cerner Corporation
• Nuance Communications
• Health Catalyst, Inc.
• Hbi Solutions
• Johns Hopkins University
• Lightbeam Health Solutions
• Dynamic Healthcare Systems

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

• Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
• Scientific and technical writings for product information and related preemptions
• Regional government and statistical databases for macro analysis
• Authentic news articles and other related releases for market evaluation
• Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.